Figure][1] T heranostics , or radiotheranostics , is a term that describes how the same radiopharmaceutical can be used for ...
Accurate delineation of the intraprostatic gross tumor volume (GTV) is a prerequisite for treatment approaches in patients with primary prostate cancer (PCa). Prostate-specific membrane antigen PET ...
Fibroblast activation protein (FAP), a membrane-anchored peptidase, is highly expressed in cancer-associated fibroblasts in more than 90% of epithelial tumors and contributes to progression and worse ...
The growing acceptance of molecular imaging biomarkers in Alzheimer disease (AD) research and clinical trials emphasizes the need for reliable and reproducible image quantification methods. Used ...
The aim of this study was to evaluate the physical performance of the Vereos whole-body PET/CT system according to the National Electrical Manufacturers Association (NEMA) NU2-2012 standard and to ...
Journal of Nuclear Medicine October 2025, jnumed.124.269188; DOI: https://doi.org/10.2967/jnumed.124.269188 ...
The development of folic acid–based radioconjugates has been proposed for imaging and targeted radionuclide therapy of folate receptor-α (FRα)–positive cancer. Although folic acid binds both the tumor ...
Journal of Nuclear Medicine January 2026, jnumed.125.271273; DOI: https://doi.org/10.2967/jnumed.125.271273 ...
Imaging of amyloid deposition using PET has been available in research studies for 2 decades and has been approved for clinical use by the U.S. Food and Drug Administration, the European Medicines ...
The radiomicrosphere treatment concept was introduced during the 1960s, and the techniques and clinical applications have been extensively described in the literature (1–5). The delivery of radiation ...
The internal dosimetry schema of the Medical Internal Radiation Dose (MIRD) Committee of the Society of Nuclear Medicine has provided a broad framework for assessment of the absorbed dose to whole ...
Prognostic Value of Early Follow-Up PSMA PET/CT After 2 Cycles of [177 Lu]Lu-PSMA RPT in Patients with mCRPC: Comparison with PSA Dynamics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results